Eisai EMEA Revenue and Competitors

Hatfield, UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Eisai EMEA's estimated annual revenue is currently $228.9M per year.(i)
  • Eisai EMEA's estimated revenue per employee is $235,050

Employee Data

  • Eisai EMEA has 974 Employees.(i)
  • Eisai EMEA grew their employee count by 4% last year.

Eisai EMEA's People

NameTitleEmail/Phone
1
Head UK Medical Affairs, Neurology & Alzheimer's Disease EISAI EUROPEReveal Email/Phone
2
QA and PV Safety OfficerReveal Email/Phone
3
Head Medical Affairs OncologyReveal Email/Phone
4
Executive Director, Head EMEA Marketing, NeurologyReveal Email/Phone
5
Director, Head Discovery Project ManagementReveal Email/Phone
6
Director, Integrated Oncology Data Services, Oncology Business GroupReveal Email/Phone
7
Brand Director Oncology EMEAReveal Email/Phone
8
Sales and Marketing Director - Oncology and NeurologyReveal Email/Phone
9
Market Access & Commercial DirectorReveal Email/Phone
10
Market Access & Medical Director, Eisai IsraelReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.9M26510%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$113.4M4752%N/AN/A
#4
$20.9M893%N/AN/A
#5
$37M1849%N/AN/A
#6
$45.4M62-67%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$8M369%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

What Is Eisai EMEA?

Welcome to the Eisai EMEA. Eisai (pronounced 'Ä?-zÄ«â??) is derived from the Japanese word for 'health product' and, here at Eisai, we discover, develop and market innovative, high quality medicines throughout the world. \n\nEisai is one of the world's leading research-based pharmaceutical companies. We define our corporate mission as "giving first thought to patients and their families, and to increasing the benefits health care provides," which we call human health care (hhc). With operations in the U.S., Asia, Europe, Russia, India, Africa, the Middle East, Australia and it's domestic home market of Japan, Eisai employs more than 11,000 people worldwide.\n\nOur main focuses are within Oncology & Neurology (dementia-related diseases and neurodegenerative diseases).

keywords:N/A

N/A

Total Funding

974

Number of Employees

$228.9M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Eisai EMEA News

2022-03-22 - Eisai hands off responsibility for Aduhelm to Biogen -

Japanese pharma Eisai has backed away from its 50:50 profit-sharing arrangement with ... which have held up approvals in Europe and Japan.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$473.6M114922%N/A
#2
$752.2M199014%N/A
#3
$660.4M202923%N/A
#4
$582.6M329519%N/A
#5
$1479.6M343911%N/A